Dr. Fadi Braiteh, MD
Claim this profileComprehensive Cancer Centers of Nevada
Studies Solid Tumors
Studies Non-Small Cell Lung Cancer
19 reported clinical trials
34 drugs studied
About Fadi Braiteh, MD
Education:
- Graduated with an MD from the American University of Beirut Faculty of Medicine, Lebanon, in 1996.
- Completed a Residency in Internal Medicine at the University of Nevada School of Medicine in 2000.
- Finished a Fellowship in Hematology/Oncology at the University of Nevada School of Medicine in 2003.
Experience:
- Currently serves as a medical oncologist and hematologist at Comprehensive Cancer Centers of Nevada.
Area of expertise
1Solid Tumors
Stage IV
BRAF positive
Stage III
2Non-Small Cell Lung Cancer
Stage IV
Stage III
metastatic
Affiliated Hospitals
Clinical Trials Fadi Braiteh, MD is currently running
Tazemetostat
for Advanced Cancer with Liver Impairment
This trial tests tazemetostat, an oral medication, in patients with advanced solid tumors and different liver functions. It aims to understand how the drug behaves in the body and its safety. Researchers will measure drug levels in the blood and monitor for side effects. Tazemetostat is approved by the FDA for certain types of cancer.
Recruiting1 award Phase 1
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
More about Fadi Braiteh, MD
Clinical Trial Related4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Fadi Braiteh, MD has experience with
- Pembrolizumab
- PD-1 Inhibitor
- Nivolumab
- ABM-1310
- Cobimetinib
- CAB-ROR2-ADC
Breakdown of trials Fadi Braiteh, MD has run
Solid Tumors
Non-Small Cell Lung Cancer
Breast Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fadi Braiteh, MD specialize in?
Fadi Braiteh, MD focuses on Solid Tumors and Non-Small Cell Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are BRAF positive.
Is Fadi Braiteh, MD currently recruiting for clinical trials?
Yes, Fadi Braiteh, MD is currently recruiting for 7 clinical trials in Las Vegas Nevada. If you're interested in participating, you should apply.
Are there any treatments that Fadi Braiteh, MD has studied deeply?
Yes, Fadi Braiteh, MD has studied treatments such as Pembrolizumab, PD-1 inhibitor, Nivolumab.
What is the best way to schedule an appointment with Fadi Braiteh, MD?
Apply for one of the trials that Fadi Braiteh, MD is conducting.
What is the office address of Fadi Braiteh, MD?
The office of Fadi Braiteh, MD is located at: Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada 89169 United States. This is the address for their practice at the Comprehensive Cancer Centers of Nevada.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.